Skip to content

Protective Effect of RIPC Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII)

Protective Effect of Remote Ischemic Preconditioning (RIPC) Against Negative Inflammatory Response and Organ Dysfunction After Cardiovascular Surgery (Panda VII)

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06707350
Acronym
PANDA
Enrollment
500
Registered
2024-11-27
Start date
2024-12-01
Completion date
2025-12-31
Last updated
2024-11-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary Bypass, Cardiovascular Diseases, Inflammatory Response During Cardiac Surgery

Keywords

inflammation

Brief summary

Remote ischaemic pre-conditioning (RIPC) has been recognized as a low-cost, non-invasive intervention method by applying brief ischaemia and reperfusion on an arm or a leg. Previous studies have mainly focused on the organoprotective effects of RIPC in patients undergoing cardiac surgery. However, whether it has an organ-protecting effect is still highly debated. We aimed to determine whether intensive RIPC can prevent from negative inflammatory response and organ dysfunction as well as postoperative complications in patients undergoing cardiovascular surgery.

Interventions

DEVICERemote ischemic preconditioning (RIPC)

8 cycles of 5-minute inflation and 5-minute deflation on 2 upper and lower limbs with a blood pressure cuff

DEVICEsham condition (control group)

8 cycles of 5-minute inflation to a pressure of 20 mm Hg followed by 5-minute cuff deflation.

Sponsors

The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* patients at high risk for organ dysfunctions who underwent elective cardiovascular surgery requiring cardiopulmonary bypass (CPB); * age of 18 -80 years old, regardless of gender; * subjects voluntarily participate in the trialand sign the informed consent;

Exclusion criteria

* 1\) Arm fracture, skin injury or infection; * 2\) There is limb nerve injury; * 3\) Limb placement PICC, arteriovenous fistula and other devices that affect armband placement; * 4\) There are basic vascular lesions and poor blood supply at the extremities; * 5\) Limb thrombosis.

Design outcomes

Primary

MeasureTime frameDescription
∆SOFAwithin the prior 7 days after cardiac surgery.the change in sequential organ failure assessment score \[∆SOFA\]) was defined as the difference between the mean total postoperative SOFA score, calculated maximally to the 9th postoperative day, and the basal SOFA score.

Secondary

MeasureTime frameDescription
Plasma interleukin-1 levelswithin the prior 7 days after cardiac surgery.Plasma interleukin-1 levels within the prior 7 days after cardiac surgery.

Countries

China

Contacts

Primary ContactHong Liu, MD
dr.hongliu@foxmail.com18801281613
Backup ContactYong-feng Shao, MD
yfshaojph@sina.com02568303101

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026